Follicular Lymphoma Foundation Logo
Your support hub
Donate

2024 End of Year Reflections:
Celebrating Progress, Gratitude, and Hope

As 2024 comes to a close, we at the Follicular Lymphoma Foundation (FLF) are filled with pride and gratitude. This year has been transformative, marked by groundbreaking progress in our mission to cure follicular lymphoma.

Your unwavering and generous support has fueled our achievements, and as we reflect on the year, we also look ahead with hope and determination for an even brighter 2025.

Key Achievements in 2024

1. Advancing Research with Patient-centric Focus

We collaborated with leading global companies and top experts to accelerate innovative treatments and advance scientific understanding, ensuring research is strategically coordinated and focused on real patient outcomes.

Patient input—through patient review panels, focus groups and surveys, patients played a critical role in shaping research priorities and driving meaningful discussions.

Major Research Highlights: 

  • CURE FL Awards
    • Cycle 1 continues to make exciting progress, it has successfully completed its second year of research and is now paving the way for clinical trials.
    • Cycle 2 launched in partnership with Leukemia & Lymphoma Society (LLS) and the Institute for Follicular Lymphoma Innovation (IFLI) awarding $2.25 million to three pioneering research projects aimed at transforming patient outcomes.
  • Biomarker Discovery Program
    • In partnership with the Mark Foundation for Cancer Research.
    • Launched to address the critical need for biomarkers that can identify high-risk patients, guide treatment decisions, and serve as interim endpoints for evaluating therapies. 
  • PETReA Plus
    • In partnership with Blood Cancer UK and the Joyce and Norman Freed Foundation.
    • Funding a world-leading study led by Dr Kim Linton at The Christie Hospital in Manchester, UK. This project, which is part of an ongoing clinical trial, will give us a better understanding of how we can improve patient outcomes.
Learn more about our Research Programs
CURE FL researchers
CURE FL Cycle 2 logo
UPENN

2.  Empowering Patients through Community and Education

Our patient-centric approach empowers individuals with the knowledge they need to navigate their journey with follicular lymphoma. Our priority for patient involvement at every stage, inspired by what they tell us matters most. We ensure everything is co-designed with patients for maximum impact.

Patient Empowerment Highlights: 

“Great insight into how treatments continue to progress and so comforting to know others have the same concerns and questions as I have. This makes me feel less alone.” 

– Patient Feedback on Relapsed FL Webinar

Explore Your Support Hub
Survey results
Photo of FL patient Jacqueline
Webinar image

3.  Educating Physicians Through Scientific Events

By fostering collaboration and knowledge-sharing, we empower physicians with the tools and insights needed to improve patient outcomes and enhance quality of life.

Key Events:

  • ASH Annual Meeting (San Diego, US)
    • Our satellite symposium, in partnership with Clinical Care Options LLC, “A Game Changer for FL,” highlighted the latest breakthroughs in follicular lymphoma research. 
    • We also convened the CURE FL researchers to discuss ongoing projects, future visions, and the importance of expanded collaboration. 
  • European Hematology Association (EHA) Conference (Madrid, Spain)
    • Meeting with some of the leading European experts in the field.
  • Advances in Malignant Lymphoma Conference (Philadelphia, US)
    • Pioneering the Future of Immuno-Oncology in the FL Investigator Workshop.

These events foster collaboration among leading researchers and clinicians, driving innovation and improving patient outcomes. These events also provide a vital platform to amplify the patient voice and ensure that FL takes center stage in these important conference discussions.

Read about the importance of ASH
Kate, Julie and Jessica at conference
Photo of ASH sign
FLF at ASH

4.  Achieving New Fundraising Milestones

Thanks to the generosity of our supporters, 2024 was a record-breaking year for fundraising. Your contributions have enabled us to invest in cutting-edge research and expand our patient programs.

Fundraising Highlights: 

  • Unlock the Cure Gala Dinner
    • Raised over £800,000 to support critical research and patient services, showcasing the generosity and commitment of our community.
  • Global Community Fundraising
    • A testament to the power of our global community, with individuals and groups uniting across continents to support our mission through creative events and personal challenges.
  • Partnerships & Major Donor Support
    • Strengthened collaborations with corporate partners, trusts, and major donors who share our vision for a future free of follicular lymphoma, enabling groundbreaking projects and initiatives.
See how you can get involved in 2025
Golf Fundraising Image
Jess and Nicola
Fundraising images

A Heartfelt Thank You

These achievements would not have been possible without you—our incredible community of patients, caregivers, donors, partners, and advocates. You are the driving force behind our progress.

  • To follicular lymphoma patients and caregivers: Your courage and resilience inspire us every day. Your input drives our programs and research.
  • To our donors, corporate partners, and fundraisers: Your generosity fuels the research and programs that bring us closer to a cure.
  • To our research partners and healthcare professionals: Your tireless commitment to innovation is making a tangible difference in the lives of patients worldwide.

Help Us Start 2025 Strong

While we are proud of all we have achieved in 2024, we know there is still much work to be done.

In 2025, we aim to:

  • Expand our research funding to support innovative projects with the potential to transform patient care.
  • Enhance our patient programs to provide even more resources, education, and support.
  • Raise global awareness about follicular lymphoma, ensuring more patients have access to the care and treatments they need.

As we celebrate the success of 2024 and look ahead to the promising opportunities of 2025, your support is more critical than ever. Together, we can continue driving groundbreaking research and transforming lives. 

Join us in starting the year strong—make a donation today and be part of the movement to find a cure for follicular lymphoma.

DONATE TODAY